Skip to main content
Clinical Trials/CTRI/2008/091/000280
CTRI/2008/091/000280
Completed
Phase 4

A double blind comparative randomized study evaluating the efficacy and safety of combined application of topical diltiazem and lignocaine as compared to topical dilitazem and lignocaine alone in the management of anal fissures

Troikaa Pharmaceuticals Limited0 sites75 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- Patients of Chronic Anal Fissures
Sponsor
Troikaa Pharmaceuticals Limited
Enrollment
75
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Adult patients aged between 18 \- 60 years.
  • 2\.Patients with a diagnosis of chronic anal fissure
  • 3\.Patients with symptoms persisting after 2 weeks of standard management (diet, laxatives, Sitz\-baths)

Exclusion Criteria

  • 1\.Patients having anal fistulas or anal fissure of various causes such as Crohn disease, anal suppuration, abscesses,
  • 2\.Patients with associated acute haemorrhoidal attacks
  • 3\.Patients having anal or perianal cancer
  • 4\.Patients who have been surgically treated previously
  • 5\.Pregnant women
  • 6\.Patients of hypertension / IHD on oral CCBs.
  • 7\.Known hypersensitivity to either dilitiazem or lignocaine
  • 8\.Pregnant women /lactating mother
  • 9\.Patients talking CCB, Nitrates, vasodilator
  • 10\.Patients with HIV infection

Outcomes

Primary Outcomes

Not specified

Similar Trials